National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings, 48820-48821 [2016-17547]
Download as PDF
<![CDATA[
48820
Federal Register / Vol. 81, No. 143 / Tuesday, July 26, 2016 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
srobinson on DSK5SPTVN1PROD with NOTICES
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Conduct the initial scientific peer
review and assess the merit of Research
Centers in Injury and Peri-operative Sciences.
Date: August 2, 2016.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Contact Person: Lisa A. Newman, SCD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, Building 45, Room 3AN18,
Bethesda, MD 20892–4874, (301)435–0965,
newmanla2@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Conduct the initial scientific peer
review and assess the merit of Clinical Trail
Research Project Grants.
Date: August 4, 2016.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Contact Person: Lisa A. Newman, SCD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, Building 45, Room 3AN18,
Bethesda, MD 20892–4874, (301)435–0965,
newmanla2@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: July 20, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–17561 Filed 7–25–16; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
20:28 Jul 25, 2016
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
NHLBI K08 Review Meeting.
Date: August 15, 2016.
Time: 12:00 p.m. to 12:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7186, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Keith A. Mintzer, Ph.D.,
Scientific Review Officer, Office of Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7186, Bethesda, MD 20892–7924, 301–594–
7947, mintzerk@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: July 20, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Support of Competitive Research
(SCORE).
Date: August 2, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3An.12N, 45 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Margaret J. Weidman,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18B, Bethesda, MD
20892, 301–594–3663, weidmanma@
nigms.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: July 20, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–17560 Filed 7–25–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–17548 Filed 7–25–16; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\26JYN1.SGM
26JYN1
Federal Register / Vol. 81, No. 143 / Tuesday, July 26, 2016 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group Clinical, Treatment and
Health Services Research Review
Subcommittee.
Date: October 11, 2016.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Alcohol &
Alcoholism, Terrace Level Room 508–509,
5635 Fishers Lane, Rockville, MD 20852.
Contact Person: Ranga V. Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@
mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group, Epidemiology, Prevention
and Behavior Research Review
Subcommittee.
Date: October 18, 2016.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Alcohol &
Alcoholism, Terrace Level Room 508–509,
5635 Fishers Lane, Rockville, MD 20852.
Contact Person: Anna Ghambaryan, M.D.,
Ph.D., Scientific Review Officer, Extramural
Project Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, 5635 Fishers Lane,
Room 2019, Rockville, MD 20852, 301–443–
4032, anna.ghambaryan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: July 20, 2016.
Melanie J. Gray-Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–17547 Filed 7–25–16; 8:45 am]
BILLING CODE 4140–01–P
srobinson on DSK5SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Medication Assisted Treatment for
Opioid Use Disorders Reporting
Requirements
Substance Abuse and Mental
Health Services Administration,
AGENCY:
VerDate Sep<11>2014
20:28 Jul 25, 2016
Jkt 238001
Department of Health and Human
Services (HHS).
ACTION: Notice of Public Listening
Session.
The Substance Abuse and
Mental Health Services Administration
(SAMHSA) announces that it will hold
a public listening session on August 2,
2016, to solicit comments regarding the
supplemental notice of proposed
rulemaking, ‘‘Medication Assisted
Treatment for Opioid Use Disorders
Reporting Requirements.’’ The session
will be held in Rockville, MD, to obtain
direct public input from stakeholders on
the proposed reporting requirements.
DATES: The listening session will be
held on August 2, 2016, from 3:00 to
5:00 p.m.
ADDRESS: Participation: The listening
session will be held at the Substance
Abuse and Mental Health Services
Administration at 5600 Fishers Lane,
Rockville, MD 20857, Room 5N54.
SAMHSA will post the agenda and
logistical information on how to
participate in person or by phone on
https://www.eventbrite.com/e/publiclistening-session-mat-for-opioid-usedisorder-reporting-requirements-tickets26685870156 in advance of the listening
session.
The session is open to the public and
the entire meeting’s proceedings will be
recorded and made publicly available.
Interested parties may participate in
person or by phone. Capacity is limited
and registration is required. To register,
go to https://www.eventbrite.com/e/
public-listening-session-mat-for-opioiduse-disorder-reporting-requirementstickets-26685870156. Registration will
be open until we meet maximum
capacity. In addition to attending the
session in person and joining via phone,
the Agency offers several ways to
provide comments in advance of the
listening session, as enumerated below.
The forum will begin with opening
remarks from the SAMHSA official
charged with moderating the session.
The session is accessible to persons
with disabilities.
You may submit comments using any
of the following methods:
• Mail: The Substance Abuse and
Mental Health Services Administration,
5600 Fishers Lane, Room 13E21C,
Rockville, MD 20857
• Hand Delivery or Courier: 5600
Fishers Lane, Room 13E21C, Rockville,
MD 20857 between 9 a.m. and 5 p.m.,
ET, Monday through Friday, except
federal holidays.
• Email: WaiverRegulations@
SAMHSA.hhs.gov.
Each submission must include the
Agency name and the docket number for
SUMMARY:
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
48821
this notice. Comments must be received
by 5:00 p.m. ET on August 8, 2016.
FOR FURTHER INFORMATION CONTACT: For
information concerning the listening
session or the live webcast, please
contact: Phillip Ames, Special Assistant,
SAMHSA, 5600 Fishers Lane, 18E61,
Rockville, MD 20857, (240) 276–2129 or
email WaiverRegulations@
SAMHSA.hhs.gov.
Background
On March 30, 2016 HHS issued a
Notice of Proposed Rulemaking (NPRM)
entitled ‘‘Medication Assisted
Treatment for Opioid Use Disorders’’ in
the Federal Register. On July 8, 2016,
HHS published a final version of this
rule with the same title. The final rule
increases access to medication-assisted
treatment (MAT) with certain
medications, including buprenorphine
and combination buprenorphine/
naloxone (hereinafter referred to as
buprenorphine) medications, in officebased setting as authorized under
section 303(g)(2) of the Controlled
Substances Act (CSA) (21 U.S.C.
823(g)(2)). Section 303(g)(2) of the CSA
allows individual practitioners to
dispense or prescribe Schedule III, IV,
or V controlled substances that have
been approved by the Food and Drug
Administration (FDA) without obtaining
a separate registration to dispense
narcotic maintenance and detoxification
drugs under section 303(g)(1). Section
303(g)(2)(B)(iii) of the CSA also allows
qualified practitioners who file an
initial notification of intent (NOI) to
treat a maximum of 30 patients at a time
with medications covered under section
303(g)(2)(C). After 1 year, the
practitioner may file a second NOI
indicating his/her intent to treat up to
100 patients at a time. The final rule
expands access to MAT by allowing
eligible practitioners to request approval
to treat up to 275 patients under section
303(g)(2) of the CSA. The final rule
includes requirements to help ensure
that patients receive the full array of
services that comprise evidence-based
MAT and minimize the risk that the
medications provided for treatment are
misused or diverted.
The March 30, 2016 NPRM included
a set of reporting requirements for
practitioners who were approved to
treat patients at the higher patient limit.
The purpose of the proposed reporting
requirements was to help HHS assess
practitioner compliance with the
additional responsibilities of
practitioners who are authorized to treat
up to the higher patient limit. The
proposed reporting requirements are as
follows:
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 81, Number 143 (Tuesday, July 26, 2016)]
[Notices]
[Pages 48820-48821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-17547]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material,
[[Page 48821]]
and personal information concerning individuals associated with the
grant applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Initial Review Group Clinical, Treatment and Health
Services Research Review Subcommittee.
Date: October 11, 2016.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Alcohol & Alcoholism, Terrace Level
Room 508-509, 5635 Fishers Lane, Rockville, MD 20852.
Contact Person: Ranga V. Srinivas, Ph.D., Chief, Extramural
Project Review Branch, National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health, 5365 Fishers Lane, Room
2085, Rockville, MD 20852, (301) 451-2067, srinivar@mail.nih.gov.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Initial Review Group, Epidemiology, Prevention and
Behavior Research Review Subcommittee.
Date: October 18, 2016.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Alcohol & Alcoholism, Terrace Level
Room 508-509, 5635 Fishers Lane, Rockville, MD 20852.
Contact Person: Anna Ghambaryan, M.D., Ph.D., Scientific Review
Officer, Extramural Project Review Branch, Office of Extramural
Activities, National Institute on Alcohol Abuse and Alcoholism, 5635
Fishers Lane, Room 2019, Rockville, MD 20852, 301-443-4032,
anna.ghambaryan@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.271,
Alcohol Research Career Development Awards for Scientists and
Clinicians; 93.272, Alcohol National Research Service Awards for
Research Training; 93.273, Alcohol Research Programs; 93.891,
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical
Research and Research Support Awards., National Institutes of
Health, HHS)
Dated: July 20, 2016.
Melanie J. Gray-Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-17547 Filed 7-25-16; 8:45 am]
BILLING CODE 4140-01-P
